Scott A. Ezell

748 total citations
11 papers, 552 citations indexed

About

Scott A. Ezell is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Scott A. Ezell has authored 11 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Genetics. Recurrent topics in Scott A. Ezell's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Scott A. Ezell is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Scott A. Ezell collaborates with scholars based in United States, United Kingdom and Greece. Scott A. Ezell's co-authors include Philip N. Tsichlis, Ioannis Sanidas, Teeru Bihani, Maria Hatziapostolou, Ailan Guo, Michael J. Comb, Christos Polytarchou, Filippos Kottakis, Shaun Grosskurth and Lan Hu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular Cell and Cancer Research.

In The Last Decade

Scott A. Ezell

11 papers receiving 544 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott A. Ezell United States	10	339	146	121	95	89	11	552
Lucia Nobili Italy	15	385 1.1×	120 0.8×	124 1.0×	40 0.4×	150 1.7×	24	597
Archontoula Stoffel United States	12	548 1.6×	259 1.8×	102 0.8×	32 0.3×	56 0.6×	15	826
Lee Wisner United States	8	216 0.6×	194 1.3×	77 0.6×	36 0.4×	46 0.5×	21	544
Mercedes Hernández del Cerro Spain	9	229 0.7×	134 0.9×	34 0.3×	75 0.8×	141 1.6×	9	462
Taher E.I. Taher Netherlands	8	307 0.9×	141 1.0×	75 0.6×	70 0.7×	17 0.2×	9	597
Linda W. Horton United States	9	253 0.7×	239 1.6×	144 1.2×	27 0.3×	183 2.1×	12	595
Zsuzsa Rákosy Hungary	15	277 0.8×	259 1.8×	51 0.4×	28 0.3×	26 0.3×	23	511
Melinda S. Gordon United States	10	394 1.2×	195 1.3×	74 0.6×	20 0.2×	66 0.7×	25	683
Richard Torres United States	7	421 1.2×	123 0.8×	49 0.4×	53 0.6×	15 0.2×	9	607
Petranel T. Ferrão Australia	6	336 1.0×	206 1.4×	53 0.4×	24 0.3×	101 1.1×	8	629

Countries citing papers authored by Scott A. Ezell

Since Specialization

Citations

This map shows the geographic impact of Scott A. Ezell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott A. Ezell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott A. Ezell more than expected).

Fields of papers citing papers by Scott A. Ezell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott A. Ezell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott A. Ezell. The network helps show where Scott A. Ezell may publish in the future.

Co-authorship network of co-authors of Scott A. Ezell

This figure shows the co-authorship network connecting the top 25 collaborators of Scott A. Ezell. A scholar is included among the top collaborators of Scott A. Ezell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott A. Ezell. Scott A. Ezell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kuo, Hsu-Ping, Scott A. Ezell, Karl J. Schweighofer, et al.. (2017). Combination of Ibrutinib and ABT-199 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma. Molecular Cancer Therapeutics. 16(7). 1246–1256. 45 indexed citations

Ezell, Scott A., Suping Wang, Teeru Bihani, et al.. (2016). Differential regulation of mTOR signaling determines sensitivity to AKT inhibition in diffuse large B cell lymphoma. Oncotarget. 7(8). 9163–9174. 26 indexed citations

Kuo, Hsu-Ping, Scott A. Ezell, Karl J. Schweighofer, et al.. (2016). The role of PIM1 in the ibrutinib-resistant ABC subtype of diffuse large B-cell lymphoma.. PubMed. 6(11). 2489–2501. 37 indexed citations

Kottakis, Filippos, Parthena Foltopoulou, Ioannis Sanidas, et al.. (2014). NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells. Cancer Research. 74(14). 3935–3946. 68 indexed citations

Sanidas, Ioannis, Christos Polytarchou, Maria Hatziapostolou, et al.. (2014). Phosphoproteomics Screen Reveals Akt Isoform-Specific Signals Linking RNA Processing to Lung Cancer. Molecular Cell. 53(4). 577–590. 94 indexed citations

Ezell, Scott A., Michele Mayo, Teeru Bihani, et al.. (2014). Synergistic induction of apoptosis by combination of BTK and dual mTORC1/2 inhibitors in diffuse large B cell lymphoma. Oncotarget. 5(13). 4990–5001. 41 indexed citations

Kim, Hyung-Gu, Li Tan, Ellen Weisberg, et al.. (2014). Correction to Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor. ACS Chemical Biology. 9(3). 840–840. 3 indexed citations

Bihani, Teeru, Scott A. Ezell, Brendon Ladd, et al.. (2014). Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers. Oncotarget. 6(4). 2407–2420. 53 indexed citations

Kim, Hyung-Gu, Li Tan, Ellen Weisberg, et al.. (2013). Discovery of a Potent and Selective DDR1 Receptor Tyrosine Kinase Inhibitor. ACS Chemical Biology. 8(10). 2145–2150. 115 indexed citations

10.

Ezell, Scott A. & Philip N. Tsichlis. (2012). Akt1, EMSY, BRCA2 and type I IFN signaling: A novel arm of the IFN response. Transcription. 3(6). 305–309. 11 indexed citations

11.

Ezell, Scott A., Christos Polytarchou, Maria Hatziapostolou, et al.. (2012). The protein kinase Akt1 regulates the interferon response through phosphorylation of the transcriptional repressor EMSY. Proceedings of the National Academy of Sciences. 109(10). E613–21. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact